News
Meet Ulises: A chat with Ramón Martínez Máñez (UPV)
Ramón Martínez Máñez, professor at Universitat Politècnica de València (UPV), explains in this interview how his company is contributing to the ULISES goals in the fight against cancer.
ULISES is set to develop an immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
According to the statistics from the World Health Organization, cancer is the second leading cause of death globally, counting for approximately 9.6 million deaths in 2018. This figure is expected to increase by 60% by 2040 due to the ageing and increase of the world’s population.
While cancer treatments are currently based on surgical resection of the tumour (if possible), chemotherapy, radiotherapy, target-driven therapies and immunotherapy, ULISES aims to set out an all-new therapeutic strategy based on nanotechnologies.
Ramón Martínez Máñez, professor at Universitat Politècnica de València (UPV), explains in this interview how his company is contributing to the ULISES goals in the fight against cancer.
If you’re just born in the wrong country, or social class, you may have a 60% less chance of surviving cancer. On World Cancer Day, experts call to fight “inequities”: not a matter of chance, but of modifiable factors which might save millions of lives.
Matthias Niemann, VP Technology of PIRCHE, explains in this interview how his company is contributing to the ULISES goals in the fight against cancer.